Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does VILANTEROL TRIFENATATE Cause Hyperlipidaemia? 38 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 38 reports of Hyperlipidaemia have been filed in association with VILANTEROL TRIFENATATE. This represents 9.7% of all adverse event reports for VILANTEROL TRIFENATATE.

38
Reports of Hyperlipidaemia with VILANTEROL TRIFENATATE
9.7%
of all VILANTEROL TRIFENATATE reports
38
Deaths
37
Hospitalizations

How Dangerous Is Hyperlipidaemia From VILANTEROL TRIFENATATE?

Of the 38 reports, 38 (100.0%) resulted in death, 37 (97.4%) required hospitalization, and 37 (97.4%) were considered life-threatening.

Is Hyperlipidaemia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for VILANTEROL TRIFENATATE. However, 38 reports have been filed with the FAERS database.

What Other Side Effects Does VILANTEROL TRIFENATATE Cause?

Abdominal pain (170) Appendicitis (169) Ascites (169) Abdominal distension (168) Appendicolith (168) Hyponatraemia (167) Cardiogenic shock (165) General physical health deterioration (165) Nausea (165) Stress (164)

What Other Drugs Cause Hyperlipidaemia?

ALENDRONATE (511) AMLODIPINE (226) DENOSUMAB (204) SITAGLIPTIN (186) METHOTREXATE (184) ROSUVASTATIN (179) PREDNISONE (169) FINASTERIDE (145) MYCOPHENOLATE MOFETIL (141) ASPIRIN (138)

Which VILANTEROL TRIFENATATE Alternatives Have Lower Hyperlipidaemia Risk?

VILANTEROL TRIFENATATE vs VILAZODONE VILANTEROL TRIFENATATE vs VILDAGLIPTIN VILANTEROL TRIFENATATE vs VILOXAZINE VILANTEROL TRIFENATATE vs VIMPAT VILANTEROL TRIFENATATE vs VIMSELTINIB

Related Pages

VILANTEROL TRIFENATATE Full Profile All Hyperlipidaemia Reports All Drugs Causing Hyperlipidaemia VILANTEROL TRIFENATATE Demographics